4Sharp K, Yee KM, Steward O. A reassessment of the effects of treatmentwith an epidermal growth factor receptor (EGFR) inhibitor onrecovery of bladder and locomotor function following thoracic spinalcord injury in rats[j]. Exp Neurol, 2012,233(2): 649-659.
5Ramis G, Thomas-Moya E, Fernandez DMS, et al. EGFR inhibitionin glioma cells modulates Rho signaling to inhibit cell motility andinvasion and cooperates with temozolomide to reduce cell growth [J].PLoS One, 2012,7(6): e38770.
6Cunningham C. Microglia and neurodegeneration: The role of systemicinflammation[J]. Glia, 2013,61(1): 71-90.
7Martin R, Cordova C, Nieto ML. Secreted phospholipase A2-IIA-induced a phenotype of activated microglia in BV-2 cells requiresepidermal growth factor receptor transactivation and proHB-EGFshedding[j]. J Neuroinflammation; 2012,9(1):154-174.
8Xia M; Zhu Y. Signaling pathways of ATP-induced PGE2 release inspinal cord astrocytes are EGFR transactivation-dependent[j]. Glia2011,59(4):664-674.
9Ano Y, Sakudo A, Onodera T. Role of microglia in oxidative toxicityassociated with encephalomycarditis virus infection in the centralnervous system[j]. IntJ Mol Sci, 2012,13(6):7365-7374.
10Ding WX, Shen HM, Ong CN. Critical role of reactive oxygen speciesand mitochondrial permeability transition in microcystin-inducedrapid apoptosis in rat hepatocytes[j]. Hepatology, 2000, 32(3):547-555.
